MedChemWatch, the monthly e-newsletter of EFMC, will provide you with regular updates on the activities of our National Adhering Organisations, give information on EFMC organised and sponsored events, and alert you on calls for medicinal chemistry related grants and funding opportunities.
FMC 2015 - FRONTIERS IN MEDICINAL CHEMISTRY
The 5th edition of the Frontiers in Medicinal Chemistry Meeting is scheduled for September 14-16, 2015 and will be held in Antwerp, Belgium. It is a key symposium in its field with traditionally around 300 participants, including experts in drug discovery and development, in particular medicinal and synthetic chemists, together with scientists active in the fields of computer assisted drug design, biology, DMPK, pharmacology, early toxicology, as well as chemical and pharmaceutical development. (...)
(…) The Frontiers meeting is organised on a biennial basis, as a collaboration between the ACS MediDivision and the EFMC, and for this year’s edition, the local organisers will be the Medicinal and Bioorganic Chemistry Division of the Royal Flemish Chemical Society (KVCV), the Division of Medicinal Chemistry of the Société Royale de Chimie (SRC) and the Section Medicinal Chemistry of the Royal Netherlands Chemical Society (KNCV). Following the spirit of this series, the meeting will bring together top quality speakers from the US and Europe, especially from Belgium and the Netherlands. The scientific programme as well as the list of confirmed speakers are now available on the website www.frontiers2015.org
EFMC-YMCS 2015 - 2nd EFMC YOUNG MEDICINAL CHEMIST SYMPOSIUM
In connection with the Frontiers Meeting, EFMC will organise the 2nd EFMC Young Medicinal Chemist Symposium (EFMC-YMCS). After the first edition organised in Lisbon in September 2014, which gathered 120 participants from 25 nations, the 2nd edition will be organised in Antwerp (Belgium) on September 17, 2015. (...)
(…) This one-Day Symposium has the aim of creating a network of young European investigators in Medicinal Chemistry, stimulating young European investigators in Medicinal Chemistry to share their scientific work with peers and inspiring leaders in the field, creating competition and excellence in Medicinal Chemistry within Europe by selecting the European Champion in Medicinal Chemistry.
To find out more, check the website www.efmc-ymcs.org
EFMC-ASMC'15 - 6TH EFMC INTERNATIONAL SYMPOSIUM ON ADVANCES IN SYNTHETIC AND MEDICINAL CHEMISTRY
The 6th EFMC International Symposium on Advances in Synthetic and Medicinal Chemistry (EFMC-ASMC’15) is scheduled for November 15-18, 2015 and will be held in Tel Aviv, Israel, in combination with the 13th Annual Meeting of the Medicinal Chemistry Section of the Israel Chemical Society. (...)
(…) This symposium will bring together chemists from industry, academia and start-up companies from around the world and is centered on the most recent advances in new synthetic methodologies, total synthesis, organometallic chemistry, medicinal chemistry, drug discovery and development leading to new or improved methods for the synthesis of pharmaceuticals.
Beyond key lectures in synthetic and catalytic chemistry, as well as recent case studies in medicinal chemistry and drug discovery, the symposium aims at extending the range from ‘small molecules’ to ‘large molecules’ including carbohydrates, natural products, novel protein scaffolds and genes; it is expected to attract experts in synthetic chemistry, medicinal chemistry, total synthesis, catalysis, drug discovery, molecular imaging, and chemical development.
We strongly encourage young scientists, particularly graduate students and postdoctoral fellows, to attend this symposium!
More details on the symposium as well as the list of confirmed speaker are now available on the website www.efmc-asmc2015.org
EFMC TRAVEL GRANTS
EFMC is funding grants for EFMC organised events with the aim to support the participation of young academic scientists. Upon application, up to 50% of the registration fee for EFMC-ASMC, Frontiers in Medicinal Chemistry, EFMC Short Courses or the EFMC Accredited School (Urbino) will be covered by EFMC. (...)
(…) To apply for an EFMC grant, please fill in the application form available on the website www.efmc.info and upload your CV, publication list, abstract, motivation letter and support letter from the supervisor.
Deadlines for applying can be found via this link.
NEWS FROM THE BIOLOGICAL AND MEDICINAL CHEMISTRY SECTOR (BMCS) OF THE ROYAL SOCIETY OF CHEMISTRY (UK)
The Biological and Medicinal Chemistry Sector of the Royal Society of Chemistry is pleased to invite nominations for the sixth Capps Green Zomaya Memorial Award in medicinal or computational chemistry. The Award will be given to the individual judged to have made an important contribution to the discovery or development of new medicines. (…)
(…) Nominations are invited for candidates, up to the age of 40, working in UK or international laboratories (candidates over the age of 40, who have taken career breaks, will be considered). A Royal Society of Chemistry commemorative medal and certificate will be awarded to accompany the prize of £2000.
Nominations should be submitted no later than 31st October 2015 and sent to Maggie Churchouse, RSC-BMCS Secretariat, 3 East Barn, Market Weston Road, Thelnetham, Diss IP22 1JJ, UK.
Closing date for poster submissions extended to 27th March Proteinase 2015: 9th RSC / SCI symposium on proteinase inhibitor design on 13th-14th April 2015 at Novartis, Basel, Switzerland
Still a few places available. Book early to avoid paying late fees: Nucleosides and nucleotides: synthetic and biological chemistry on 17th April 2015, Royal Society of Chemistry, London, UK
Advance notice, book early for this popular symposium: 18th RSC / SCI Medicinal Chemistry symposium on 13th -16th September 2015, Churchill College, Cambridge, UK
THE FRENCH MEDICINAL CHEMISTRY SOCIETY (SCT) ANNOUNCES THE NEXT ‘Spring One-day Thematic Symposium’, APRIL 8th, 2015 IN PARIS.
The topic of the meeting will be “Chemical Biology: Bioorthogonal Chemistry contributing to Molecular Therapeutic Innovation”. The aim of the symposium is to illustrate the great potential and the applications of bioorthogonal chemistry in chemical biology contributing to therapeutic innovation at the molecular level. (…)
(…) This meeting is dedicated to a large audience of organic and medicinal chemists, biochemists and biologists, covering various applications in biology, diagnostics and therapy.
The program consists of one introductory lecture and 6 plenary lectures, structured in 3 sessions:
- Dr. Oliver Plettenburg (Sanofi, Frankfurt am Main, Germany):’Chemical biology in pharmaceutical research’
- Dr. Gonçalo Bernardes (University of Cambridge, UK): ‘Site-selective protein modification chemistry for basic biology and drug development’
- Prof. Andres Jäschke (Universität Heidelberg, Germany): ‘Cycloaddition chemistry combined with next-generation sequencing leads to the discovery of new roles for cofactors in bacteria’
- Prof. Herman Overkleeft (Universiteit Leiden, The Netherlands):’Inhibitors and activity-based probes to study human proteasomes’
- Dr. Marc Robillard (Tagworks Pharmaceuticals, The Netherlands):’In vivo chemistry for cancer imaging and therapy’
- Dr. Boris Vauzeilles (Institut de Chimie des Substances Naturelles & Institut de Chimie Moléculaire et des Matériaux d'Orsay, France) :’Detecting living pathogens using bioorthogonal chemistry’
- Dr. Alain Wagner (Université de Strasbourg, France) :’Bioorthogonal and biospecific chemistries for biomolecule engineering’
This symposium is co-organized by: Dr Frédéric Schmidt, (Curie Institute, Paris, France), Organizing Committee chair, Dr Pascal George, SCT President 2013-2014 (Independent Scientific Expert & Adviser), Dr Jean-Claude Florent, (Curie Institute, Paris, France), Dr Michel Azoulay, (Curie Institute, Paris, France), Prof. Sébastien Papot, (University of Poitiers, France).
The program can be downloaded at http://www.sct-asso.fr/articles.php?lng=fr&pg=225
For registration, please visit our website: http://www2.sct-asso.fr/Bioorthogonal-registration
THE SWISS CHEMICAL SOCIETY (SCS) ANNOUNCED KGF-SCS AWARDS 2015
The Swiss Chemical Society and the Contact group for research matters (KGF) are proud and happy to announce the winners of the KGF-SCS Industrial Investigator Awards 2015 and to honor their outstanding achievements. We sincerely congratulate all winners and we are looking forward to the ceremonies and award lectures that will take place on the occasion of the SCS Fall Meeting in Lausanne on September 4 and 5, 2015. (…)
(…) KGF-SCS Distinguished Industrial Science Award 2015 CHF 15'000 The award is given to:
Dr. Jürg Zimmermann, Novartis Pharma AG
for the ground breaking discovery of protein kinase inhibitors, which had a tremendous impact on the research and therapy of cancer and other diseases. The discovery and development of Imatinib (Gleevec) has revolutionized the therapy of certain forms of leukemia, and also had a tremendous impact on research projects both in industry and academia.
KGF-SCS Senior Industrial Science Award 2015
The award is given to
Dr. Michelangelo Scalone, F. Hoffmann La Roche,
for his outstanding contributions to the design of new, short and cost-efficient syntheses for many development projects by applying asymmetric catalytic reactions, and for his longtime success and expertise in leading the Center of Excellence Catalysis at Roche.
KGF-SCS Industrial Science Award 2015
The award is given to
Dr. Dietmar Hüglin, BASF Schweiz AG,
for his contribution in developing new ingredients for consumer product markets and specifically for the discovery, research & development of cosmetic UV absorbers combining chemistry with nano-technology. These innovations are setting currently the global standards in high performance photo-protection of human skin.
DR DONG GUO WINS THE DUTCH MEDICINAL CHEMISTRY PRIZE 2013-2014
On March 27th, 2015 the two-yearly Dutch Medicinal Chemistry Prize for the best Dutch Ph.D. thesis in the field was awarded by the Section of Medicinal Chemistry of the Royal Netherlands Chemical Society to Dr. Dong Guo. The title of his thesis was “Drug-Target Residence Time. A case for the adenosine A1 and A2a receptors”. (...)
(...) The research was performed at the Leiden University in the group of prof. Dr Ad IJzerman and Dr Laura Heitman and the Ph.D. title was obtained in June 2014. The jury of the prize consisted of Prof. Dr Koen Augustyns (University of Antwerp), Dr Laurent Provins (UCB Pharma), Dr Floris van Delft (SynAffix) and Dr Anita Wegert (Mercachem). The prize, € 1000 (sponsored by Mercachem) and a certificate, was handed over during the yearly spring symposium in Utrecht entitled ‘Medicinal Chemistry of Protein-Protein Interactions: Challenges and Opportunities’, where Dr Dong Guo presented the winning work.
Picture: Prof. Dr Roland Pieters (new chair KNCV Section Med.Chem.), award winner Dr Dong Guo and Dr Anita Wegert (jury, sponsor Mercachem).
Useful information on the calls and programmes of the EU are available via this link.
Newsletter compiled by Gabriele Costantino
EFMC ORGANISED EVENTS
EFMC SPONSORED EVENTS
Find us on social media